MDMA for PTSD?
MDMA-assisted therapy gets one step closer to its projected 2023 FDA approval
Psilocybin for depression?
The psychedelic drug goes head-to-head with Lexapro in a recent trial
How teeth sense cold; the efficacy of digital advertising
A few things worth checking out: 05-16-2021
#159 – Peter Hotez, M.D., Ph.D.: Evolution of the anti-vaccine movement, the causes of autism, and COVID-19 vaccine state of affairs
“What started out as an anti-vaccine movement is now a movement against any kind of public health intervention and demonizing scientists and basically calling us the boogeyman.” —Peter Hotez
What gives Rice Krispies their pop and my related experiment
Explaining the Snap! Crackle! Pop! to my sons
#158 – Brian Deer: A tale of scientific fraud—exposing Andrew Wakefield and the origin of the belief that vaccines cause autism
“In science, courage isn’t about proving yourself right, it’s in your efforts to prove yourself wrong. . .to try and refute your own hypothesis.” —Brian Deer
#143 – John Ioannidis, M.D., D.Sc.: Why most biomedical research is flawed, and how to improve it
“We need to defend our method. We need to defend our principles. We need to defend the honesty of science in trying to communicate it rather than building exaggerated promises or narratives that are not realistic.” —John Ioannidis
Teaching science through the lens of discovery
Like anyone with children right now, the end of this past school year went from in-person schooling to remote learning…
Time-restricted eating: efficacy versus effectiveness
What happens when people are prescribed a treatment vs what happens when people take the treatment are two different questions.
Randomized controlled trials: when the gold standard leaves you with fool’s gold
If I told you that I read a randomized double-blinded placebo-controlled trial conducted over 5 years and carried out in over 18,000 participants, is there any scenario under which you would not believe it to be an excellent trial?